Steven Baertschi, Ph.D., is President of Baertschi Consulting, LLC, an Indiana-based firm specializing in providing solutions to the most difficult stability, impurity, analytical, solid-state, and formulation issues. Retiring from Eli Lilly and Company in early 2015, he brings more than 33 years of experience in the pharmaceutical industry to his consulting firm, with a demonstrated track record of innovation and problem-solving. He obtained his PhD in Organic Chemistry in 1989 from Vanderbilt University (Nashville, TN) joining Eli Lilly and Co. (Indianapolis, IN) that same year. While at Lilly he was responsible for developing the areas of degradation chemistry, including stress testing, photostability testing, degradation product prediction and identification, mutagenic impurity and analytical control strategies for small molecule drug candidates.
Dr. Baertschi has helped organized / Chair numerous scientific conferences and symposia on stress testing, stability, photostability, and impurities; he has published 60 scientific articles in refereed journals and 30 book chapters. He has edited two editions of a book focused on the topic of pharmaceutical stress testing and has made critical contributions to more than 15 NDA/CTD and dozens of IND/CTA submissions. Dr. Baertschi has been a member of the American Chemical Society since 1980, the American Association of Pharmaceutical Scientists (AAPS) since 1993, was named a Fellow of the AAPS in 2007, and was awarded the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who.
Click the links below to view additional profiles of Steven W Baertschi
Contracts have been established and services provided to more than 60 pharma / biotech / agriscience companies in the last 5 years!
Ph.D.,Organic Chemistry, Minor: Biochemistry, July 1989
Vanderbilt University, Nashville, TN
B.S., Chemistry, Minor: Mathematics, June 1980
CURRENT POSITION
President, Baertschi Consulting, LLC
29 years of in-depth scientific / technical experience in pharmaceutical R&D.
Providing consulting for the following industries:
- Pharmaceutical
- Animal Health
- Agrochemicals
- Consumer Healthcare
- Nutraceutical
- Weathering
On a wide range of topics including:
- Chemical, Physical, and Environmental Stability and Degradation
- Analytical and Impurity (including genotoxic impurity) Control Strategies
- Formulation Development, Excipient Compatibility, Excipient Interactions, and Stabilization
- Photostability / Photochemistry
- Regulatory Issues
- Quality-by-Design
- Scientific / Technical Staff Development
- Legal / Expert Witness / Patent Disputes
EMPLOYMENT HISTORY
Feb 2015 Retired from Lilly
Oct 2012 Promoted to Senior Research Fellow, Small Molecule Design and Development.
Oct 2005 Promoted to Research Fellow, Analytical Sciences R&D
Oct 2004 Promoted to Senior Research Advisor
Jan 2004 Title changed to Research Advisor
Jan 2003 Assumed supervision of Thermal Analysis Group
June 2001 Assumed supervision of Microcalorimetry Group
Jan 2001 Promoted to Senior Research Scientist
Jan 2000 Assumed role as Confirmation of Structure Team Leader
Jan 1994 to Dec 2000 Promoted to Research Scientist
Jan 1991 Assumed leadership for Degradation Chemistry Group
Aug. 1989 to Dec. 1994 Eli Lilly and Company
Senior Chemist, Analytical Development
Pharmaceutical Product Development
- The Albert Nelson Marquis Lifetime Achievement Recipient (2018)
- Fellow, AAPS (2007)
- Scientific Advisor, Journal of Pharmaceutical Sciences (July 2013-present).
- Member of the Editorial Advisory Board, Journal of Pharmaceutical and Biomedical Analysis, January 2010 to present
- Chair, AAPS APQ Fellows Selection Committee, 2010-2012.
- Member, AAPS Executive Fellows Selection Committee, 2010-2012.
- Member, PhRMA Limited Duration Key Initiative Team (LDKIT) for Genotoxic Impurities, ICH M7 Guidance (2010-present)
- Co-Chair, ICH M7 Degradants Subtopic Group LDKIT (2011-2015)
- Member, ICH M7 Quality Subgroup LDKIT (2011-2015)
- Member, USP Expert Panel on Impurities (2011-2015)
- Top Referee Award, 2007, Journal of Pharmaceutical Science
- Top Referee Award, 2006, Journal of Pharmaceutical and Biomedical Analysis
- Top Referee Award, 2008, Journal of Pharmaceutical and Biomedical Analysis
- Scientific Reviewer on Ph.D. Committees
- 2011: Shah Ravi Piyushkumar, National Institute of Pharmaceutical Education and Research, Served as External Reviewer of Dissertation for Ph.D. Committee; Prof. Saranjit Singh, Research Advisor (Ph.D. Pharmaceutical Sciences).
- 2006: Joergen Brustugun, University of. Oslo, Served as First Opponent for Ph.D. Defense (Ph.D. Pharmaceutical Sciences), Prof. Hanne H. Tonnesen, Research Advisor.
- Lilly Research Laboratories, President’s Recognition Award, 1999
- Lilly Research Laboratories, President’s Recognition Award, 2001
- Lilly Research Laboratories, Change the World Award, 2001/Q1
- Lilly Research Laboratories, Change the World Award, 2001/Q4
- Lilly Research Laboratories, Change the World Award, 2002/Q4
- Lilly Research Laboratories, Quality Advocate Award, 2003
Member of the American Chemical Society since 1980.- Member of the American Association of Pharmaceutical Scientists since 1991; Steering Committee Member for APQ Stability Focus Group, 2007-present; Steering Committee Member for APQ Impurities Focus Group, 2011-present.
- Commission Internationale de l’Eclairage (CIE), Topic Chair for Pharmaceutical Photostability, 2003-2009; Committee Member, Expert Working Group for “In-Use Photostability”, 2009-present.
- Pharmaceutical Photostability of Drugs Interest Group, Steering Committee Member since 1999.
- Member of the American Society for Photobiology (ASP)
- Member of the Customer Advisory Council (Weathering / Photostability) for Atlas Materials and Testing (Mount Prospect, IL).